Company registration number 11847602 (England and Wales)
ANTIGEN MC LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
PAGES FOR FILING WITH REGISTRAR
ANTIGEN MC LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
ANTIGEN MC LTD
BALANCE SHEET
AS AT
28 FEBRUARY 2025
28 February 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
981
1,574
Current assets
Debtors
4
153,693
355,905
Cash at bank and in hand
166,576
92,660
320,269
448,565
Creditors: amounts falling due within one year
5
(295,234)
(62,116)
Net current assets
25,035
386,449
Total assets less current liabilities
26,016
388,023
Provisions for liabilities
(245)
(393)
Net assets
25,771
387,630
Capital and reserves
Called up share capital
6
6
4
Profit and loss reserves
25,765
387,626
Total equity
25,771
387,630

For the financial year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 23 October 2025
K Jumani
Director
Company registration number 11847602 (England and Wales)
ANTIGEN MC LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 2 -
1
Accounting policies
Company information

Antigen MC Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Ground Floor, Finchale House, Belmont Business Park, Durham, DH1 1TW.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover derives from the principal activity of the company which is that of the provision of medical consultancy services. Income from that activity is recognised when the company becomes entitled to it.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% on cost
Computers
25% on cost
1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

ANTIGEN MC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
1
Accounting policies
(Continued)
- 3 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

ANTIGEN MC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
1
Accounting policies
(Continued)
- 4 -
1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.10

Going concern

The directors has considered the finance performance and the position of the company along with its cashflows for a period in excess of 12 months from the date of approval of these financial statements. The results of that review have led them to conclude that the company may continue to operate from its operating resources. For this reason the going concern basis of accounting has been adopted.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
3
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 March 2024
2,124
2,832
4,956
Additions
107
230
337
At 28 February 2025
2,231
3,062
5,293
Depreciation and impairment
At 1 March 2024
1,148
2,234
3,382
Depreciation charged in the year
544
386
930
At 28 February 2025
1,692
2,620
4,312
Carrying amount
At 28 February 2025
539
442
981
At 29 February 2024
976
598
1,574
ANTIGEN MC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 5 -
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
16,412
6,704
Amounts owed by group undertakings
10,000
-
0
Other debtors
127,281
349,201
153,693
355,905
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
6,102
3,035
Amounts owed to group undertakings
225,000
-
0
Corporation tax
61,267
55,571
Other creditors
2,865
3,510
295,234
62,116
ANTIGEN MC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 6 -
6
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of £1 each
3
3
3
3
Ordinary B shares of £1 each
3
1
3
1
6
4
6
4
7
Related party transactions

During the year the company received an interest free loan from a group company. At the year end the balance on the loan was £225,000. (2024: £305,670)

During the year the company provided an interest free loan to a group company. At the year end the balance on the loan was £10,000. (2024: £NIL)

8
Directors' transactions

Loans
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
Loan
-
41,919
85,550
(1,945)
125,524
41,919
85,550
(1,945)
125,524
2025-02-28 2024-03-01 false false false 23 October 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Mr K Jumani 11847602 2024-03-01 2025-02-28 11847602 2025-02-28 11847602 2024-02-29 11847602 core:FurnitureFittings 2025-02-28 11847602 core:ComputerEquipment 2025-02-28 11847602 core:FurnitureFittings 2024-02-29 11847602 core:ComputerEquipment 2024-02-29 11847602 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 11847602 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 11847602 core:ShareCapital 2025-02-28 11847602 core:ShareCapital 2024-02-29 11847602 core:RetainedEarningsAccumulatedLosses 2025-02-28 11847602 core:RetainedEarningsAccumulatedLosses 2024-02-29 11847602 core:ShareCapitalOrdinaryShareClass1 2025-02-28 11847602 core:ShareCapitalOrdinaryShareClass1 2024-02-29 11847602 core:ShareCapitalOrdinaryShareClass2 2025-02-28 11847602 core:ShareCapitalOrdinaryShareClass2 2024-02-29 11847602 core:ShareCapitalOrdinaryShares 2025-02-28 11847602 core:ShareCapitalOrdinaryShares 2024-02-29 11847602 bus:Director1 2024-03-01 2025-02-28 11847602 core:FurnitureFittings 2024-03-01 2025-02-28 11847602 core:ComputerEquipment 2024-03-01 2025-02-28 11847602 2023-03-01 2024-02-29 11847602 core:FurnitureFittings 2024-02-29 11847602 core:ComputerEquipment 2024-02-29 11847602 2024-02-29 11847602 core:CurrentFinancialInstruments 2025-02-28 11847602 core:CurrentFinancialInstruments 2024-02-29 11847602 core:WithinOneYear 2025-02-28 11847602 core:WithinOneYear 2024-02-29 11847602 bus:OrdinaryShareClass1 2024-03-01 2025-02-28 11847602 bus:OrdinaryShareClass2 2024-03-01 2025-02-28 11847602 bus:OrdinaryShareClass1 2025-02-28 11847602 bus:OrdinaryShareClass1 2024-02-29 11847602 bus:OrdinaryShareClass2 2025-02-28 11847602 bus:OrdinaryShareClass2 2024-02-29 11847602 bus:AllOrdinaryShares 2025-02-28 11847602 bus:AllOrdinaryShares 2024-02-29 11847602 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 11847602 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 11847602 bus:FRS102 2024-03-01 2025-02-28 11847602 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 11847602 bus:FullAccounts 2024-03-01 2025-02-28 xbrli:pure xbrli:shares iso4217:GBP